Piroxicam EG

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Piroxicam EG

Quick Facts

Property Description
Active ingredient Piroxicam
Forms Oral capsule, oral tablet, topical gel, injection
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
General purpose Relief of pain, swelling, and inflammation
Origin Synthetic compound (Enolic acid derivative)

What Type of Medicine is Piroxicam EG?

Piroxicam EG is a generic, synthetic pharmaceutical preparation whose active substance, Piroxicam, belongs to the oxicam subclass of Nonsteroidal Anti-inflammatory Drugs (NSAIDs), designed to provide systemic relief from pain and inflammation. The EG designation signifies its status as a generic variant of the original Piroxicam compound.

Piroxicam's classification as an enolic acid derivative places it within the broad NSAID group. A key feature that differentiates Piroxicam from many other common NSAIDs, such as ibuprofen or naproxen, is its particularly long biological half-life. This sustained action supports long-term symptomatic control for chronic inflammatory conditions, making it suitable for adult patient groups requiring continuous anti-inflammatory support.

Composition, Forms, and General Purpose

The medication's fundamental purpose is to mitigate inflammatory symptoms: inhibiting inflammation, relieving pain (analgesic effect), and reducing fever (antipyretic effect). The sole active component in Piroxicam EG is Piroxicam, which operates as a prostaglandin synthetase inhibitor, thereby directly interrupting the body’s inflammatory cascade.

To accommodate diverse therapeutic needs, Piroxicam is made available in several dosage forms, notably the oral capsule and oral tablet for systemic ingestion, as well as a topical gel for localized cutaneous delivery. Both oral and topical Piroxicam preparations are utilized for the reduction of inflammatory symptoms. This range of routes of administration provides therapeutic flexibility, allowing medical professionals to target either widespread inflammation (oral) or concentrated local pain (topical).

Regulatory References

  1. National Institutes of Health (NIH)
Advertisements

What side effects are possible with Piroxicam EG?

Possible Side Effects and Safety Information

Official regulatory documents classify adverse reactions to Piroxicam EG based on frequency and the physiological system affected. The most frequently documented effects, classified as common or very common, often involve the Gastrointestinal System, including nausea, flatulence, constipation, abdominal pain, and dyspepsia. Other common reactions are generally related to the Nervous System (headache, dizziness) and General Disorders (peripheral fluid retention or edema).

The official safety profile places significant emphasis on documenting potential Serious Adverse Reactions. These include the risk of serious Cardiovascular Thrombotic Events such as myocardial infarction (heart attack) and stroke, and serious Gastrointestinal Events, including bleeding, ulceration, and perforation of the stomach or intestines. Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson Syndrome (SJS), are also officially documented.

Safety patterns related to exposure are explicitly noted in regulatory labeling. The risk of serious cardiovascular and gastrointestinal events may occur early in treatment and is officially stated to increase with the duration of use. Serious gastrointestinal events can occur at any time, often without warning symptoms.

Regulatory safety considerations address specific populations. The use of Piroxicam is contraindicated for pain following Coronary Artery Bypass Graft (CABG) surgery. Furthermore, regulatory documents specify that use in older adults (over 70 years) is associated with a high risk of serious complications, and its use is contraindicated during the third trimester of pregnancy. Piroxicam is restricted from use in combination with other non-selective Nonsteroidal Anti-inflammatory Drugs.

Advertisements

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

Overdose with Piroxicam EG may present with documented signs primarily affecting the central nervous and gastrointestinal systems. These manifestations include symptoms such as nausea, vomiting, severe headache, agitation, confusion, and drowsiness. Other reported clinical signs are ringing in the ears (tinnitus) and reduced or absent urine output (oliguria/anuria).

The official regulatory documents classify certain outcomes as severe or life-threatening, necessitating immediate action. These include significant gastrointestinal bleeding, low blood pressure leading to shock, and serious neurological events such as convulsions (seizures) or decreased level of consciousness. The risk of these severe outcomes is noted to be greater in elderly patients and individuals with pre-existing kidney or liver disease.

Emergency Actions Required

If an overdose of Piroxicam EG is suspected, the regulatory guidance unequivocally states that you must seek immediate medical attention. Emergency services (such as 911 or the local Poison Help hotline) should be contacted without delay due to the potential for life-threatening complications.

Management in an overdose situation is strictly symptomatic and supportive, as no specific antidote is known. Officially described procedures may include monitoring of vital signs, blood and urine tests, and the administration of supportive treatments such as activated charcoal under hospital supervision.

Advertisements

Therapeutic Uses of Piroxicam EG

What Piroxicam EG Treats: Main Uses and Benefits

Piroxicam EG is used in situations involving certain distressing symptoms, where it contributes to sustained symptomatic support. Piroxicam is commonly used to help relieve symptoms related to physical discomfort. The medication is applied across domains where additional symptomatic support is needed, primarily for conditions presenting with systemic or localized discomfort.


Quick Fact: Symptomatic Relief

Quick Fact: Piroxicam EG is considered relevant for easing pain, stiffness, and swelling associated with conditions involving inflammatory processes.


Piroxicam EG is relevant for easing pain, stiffness, and swelling associated with conditions involving inflammatory processes, including rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. It is also considered relevant for the acute symptoms of gout, tendinitis, and for the cramping of primary dysmenorrhea. The medication provides support that helps ease the overall symptom burden. The sustained symptomatic support may help patients cope more steadily with the daily discomfort and stiffness. The medication may assist with maintaining functional stability when symptoms interfere with routine activities, and contributes to improving day-to-day comfort during symptomatic periods.

Regulatory References

  1. MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Official Eligibility and Non-Eligibility Rules

Piroxicam EG is an oral NSAID whose eligibility is strictly defined by government regulatory documents, focusing on patient status and concurrent health conditions. These rules outline absolute prohibitions and necessary restrictions.

Category Eligibility Status as per Regulatory Labeling
Approved Age Group Generally established for adults (18 years and older).
Pediatric Use Not recommended for children and adolescents under 18 due to lack of established safety and efficacy data.
Older Adults Use requires special caution; patients over 70 and especially over 80 are at increased risk and often require gastro-protective co-treatment.
Pregnancy Contraindicated in the third trimester (starting at 30 weeks gestation). Use between 20 and 30 weeks is restricted and only permitted if necessary.
Lactation Not recommended for nursing mothers.

Absolute Contraindications

Piroxicam EG must not be used by patients with:

  • A known hypersensitivity to piroxicam, aspirin, or any other NSAID.
  • Active gastrointestinal (GI) ulceration, bleeding, or perforation, or a history of severe GI events related to previous NSAID use.
  • Severe heart failure or severe renal or hepatic impairment.
  • Concurrent use of oral anticoagulants, other NSAIDs, or aspirin at analgesic doses.
  • Coronary Artery Bypass Graft (CABG) surgery (for peri-operative pain).
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define specific co-administration restrictions for Piroxicam based on the risk of increased bleeding, compromised efficacy, or altered plasma exposure.

Contraindicated and Restricted Combinations

The co-administration of Piroxicam with other systemic Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including COX-2 selective agents and analgesic doses of aspirin, must be avoided due to a significantly increased risk of serious gastrointestinal ulceration and bleeding. Concomitant use with oral anticoagulants, such as warfarin and Direct Oral Anticoagulants (DOACs), is generally not recommended as it increases the risk of bleeding events.

Pharmacodynamic and Exposure Interactions

Piroxicam may diminish the antihypertensive effect of agents like ACE Inhibitors, Angiotensin Receptor Blockers (ARBs), and Beta-Blockers. It can also reduce the natriuretic effect of loop and thiazide diuretics. Co-administration with drugs that interfere with hemostasis, including SSRIs/SNRIs and anti-platelet agents, results in an increased risk of bleeding.

Certain co-administered medicines may experience increased serum concentrations, including lithium, digoxin, and methotrexate, often due to altered clearance rates.

Metabolic and Substance-Related Constraints

Piroxicam is metabolized by the enzyme CYP2C9. Individuals identified as poor CYP2C9 metabolizers may exhibit abnormally high plasma levels and reduced metabolic clearance of Piroxicam, which regulatory information advises to consider for management. Ingestion of alcohol is a documented risk factor that significantly increases the risk of serious gastrointestinal complications.

Advertisements

Mechanism of Action

Piroxicam acts by intervening directly in the biochemical processes that mediate inflammatory responses and nociceptive signaling within the body. Its mechanism maintains continuous modulation of these processes through three primary domains.

Enzyme Inhibition and Prostaglandin Modulation

This domain covers the primary biological targets: the Cyclooxygenase (COX-1 and COX-2) enzymes. Piroxicam functions as a non-selective inhibitor, blocking these enzymes and thereby halting the synthesis of prostaglandins (PGs) from the arachidonic acid cascade. This fundamental molecular blockage underlies the physiological consequences of suppressed inflammation and nociceptor sensitization.


Suppression of Inflammatory Cell Activity

This mechanism addresses the drug's action at the cellular level, particularly its effect on neutrophil function and membrane stability. Piroxicam stabilizes lysosomal membranes and decreases the generation of reactive oxygen species (ROS), constraining the spread of tissue-damaging factors during the active inflammatory response.


Central and Peripheral Signaling Cascade

This domain links the reduction in PGs to systemic physiological consequences. Decreased peripheral PGs decrease nociceptor sensitization, while the central suppression of PGE2 synthesis in the hypothalamus re-establishes the thermoregulatory set-point. This cascade results in the physiological modulation of nociceptive signaling and the antipyretic physiological response.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

Piroxicam EG (piroxicam) is typically administered orally for the management of conditions like osteoarthritis and rheumatoid arthritis. Usage must strictly follow the dosing rules and conditions established in official regulatory documents.

Administration Scope Official Instruction
Route Oral (by mouth)
Standard Dosing 20 mg once daily
Maximum Dose 20 mg per day
Dosing Principle Use the lowest effective dosage for the shortest duration consistent with treatment goals.
Timing & Food Should be taken with or after food to help reduce the risk of stomach irritation.
Frequency Once daily is the standard. The total daily dose may be divided (e.g., 10 mg twice daily) if prescribed.

Procedural Rules

  1. Preparation: Swallow the capsule whole with a cup of water. Do not crush, chew, or break the capsule.
  2. Consistency: Take the medicine at around the same time each day to maintain consistent levels in the body.
  3. Missed Dose: If a dose is missed, take it as soon as you remember. If it is almost time for the next scheduled dose, skip the missed dose and resume the regular schedule. Do not take a double dose to make up for a missed one.
  4. Pediatric Use: Dosing for Juvenile Rheumatoid Arthritis (JRA) is determined by body weight, and use in children under 12 is generally not recommended or requires specific weight-based prescription by a physician.
  5. Reassessment: For continued use, the benefit and safety of treatment should be formally reassessed by a physician within 14 days of initiation.
Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Piroxicam EG


Evidence for Use in Chronic Inflammatory Arthritis (Osteoarthritis and Rheumatoid Arthritis)

The evidence base for Piroxicam EG in Osteoarthritis (OA) and Rheumatoid Arthritis (RA) has been explored through various scientific investigations. This research includes numerous Randomized Controlled Trials (RCTs) and comprehensive Meta-analyses focused on detailing the types of studies that explored outcomes related to physical discomfort and functional limitations. Findings describe patterns observed in the study populations related to measurements of morning stiffness and pain scores. These studies contribute to the broader evidence landscape. What remains unclear is the long-term characterization of these outcomes, as the majority of data comes from trials with a short-term follow-up.


Evidence for Use in Acute Inflammatory Conditions (Gout and Soft-Tissue Disorders)

Research exploring Piroxicam was studied for conditions characterized by acute or disruptive episodes, including trials for sudden, severe pain, such as an acute gout flare, and conditions like soft-tissue trauma. These studies were typically short-term in design. For acute gout, the research examined episodes where symptoms become more noticeable, monitoring outcomes related to pain severity and the changes in monitored local symptoms. The evidence for these acute conditions is generally observed to have limitations, such as those related to follow-up duration, and the evidence quality varies across studies.


What Remains Uncertain About the Research Landscape

The evidence base for Piroxicam provides a context for understanding symptom patterns, but there are areas where research is still developing or limited. A key limitation is that comparative evidence is lacking for some of the indications when assessing against all available treatments. Research highlights that studies often had modest sample sizes for certain groups, such as children and adolescents. The evidence highlights what is known—and what is still uncertain. Findings describe group patterns, not personal outcomes, meaning research does not determine whether an individual will respond similarly.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Piroxicam EG (FAQ)

Q: What is Piroxicam EG and how does it work?

Piroxicam EG is a medicine whose active ingredient is piroxicam. It belongs to a group of medicines called Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). It works by blocking the production of certain substances in the body, primarily prostaglandins, which are involved in causing pain, swelling, and fever. By reducing these substances, it helps to alleviate pain and inflammation.


Q: What conditions is Piroxicam EG used to treat?

Piroxicam EG is typically used for the symptomatic relief of pain and inflammation in certain long-term, chronic conditions. It is mainly prescribed for conditions such as:

  • Rheumatoid arthritis
  • Osteoarthritis (arthrosis)
  • Ankylosing spondylitis

Due to the risk of side effects, it is usually only prescribed when other NSAIDs have not provided adequate relief. The decision to use Piroxicam EG is made carefully by a doctor.


Q: How should I take Piroxicam EG?

Always take Piroxicam EG exactly as your doctor has told you. Do not exceed the prescribed dose.

  • It is generally taken once daily.
  • It can be taken with or without food, but taking it with food or milk may help reduce potential stomach irritation.
  • Swallow the tablets whole with a glass of water.
  • Your doctor will prescribe the lowest effective dose for the shortest possible duration to minimize risks.
  • If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not take a double dose to make up for a missed one.

Q: Who should not take Piroxicam EG?

Piroxicam EG is not suitable for everyone. You must not take this medicine if you have:

  • A history of stomach or intestinal ulcers, bleeding, or perforation.
  • A history of gastrointestinal disorders such as ulcerative colitis or Crohn's disease.
  • A severe allergic reaction (such as asthma, rhinitis, or rash) after taking piroxicam or other NSAIDs (like aspirin or ibuprofen).
  • Severe heart failure.
  • Severe kidney or liver problems.
  • Bleeding problems or a history of stroke due to bleeding.
  • Are in the last three months of pregnancy.
  • Are taking other NSAIDs or anticoagulants (like warfarin) at the same time.

It is crucial to inform your doctor about your complete medical history before starting Piroxicam EG.


Q: What are the potential side effects of Piroxicam EG?

Like all medicines, Piroxicam EG can cause side effects, although not everyone gets them. Gastrointestinal (GI) side effects and cardiovascular risks are serious concerns with NSAIDs like piroxicam.

Common side effects may include:

  • Stomach discomfort or pain, nausea, vomiting, indigestion (dyspepsia).
  • Dizziness, headache.

Serious side effects requiring immediate medical attention include:

  • Signs of GI bleeding: Black, tarry stools, or vomiting blood.
  • Signs of an allergic reaction: Swelling of the face, lips, tongue, or throat, difficulty breathing, severe skin rashes.
  • Signs of a heart problem: Chest pain, shortness of breath, weakness, or slurred speech.

Your doctor will discuss the potential risks versus benefits before prescribing Piroxicam EG.

Advertisements

How should Piroxicam EG be stored and disposed of?

Storage and Disposal of Piroxicam EG

The medicine must be stored at controlled room temperature, typically 20 C to 25 C, and excursions between 15 C and 30 C are acceptable. It is mandatory to keep Piroxicam EG from freezing and away from excessive heat and moisture. Storage must be in the original, tightly closed container.

Child Safety

The product must be kept out of the reach and sight of children to prevent accidental ingestion.

Disposal

Unused or expired Piroxicam EG must be disposed of in accordance with local regulatory requirements. The medicine should not be discarded into household waste or wastewater, and patients should consult a healthcare professional regarding proper disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Piroxicam EG found in:

A-Z Index: